EPISODE · Nov 14, 2024 · 38 MIN
Ep 52: knownwell CMO Dr. Angela Fitch on The Future of GLP-1s and New Approaches to Obesity Medicine
from Vital Signs with Jacob Effron and Nikhil Krishnan · host Angela Fitch, Jacob Effron
Jacob sits down with Dr. Angela Fitch, the Founder and CMO of knownwell. knownwell has raised $25 million from investors like a16z and Flare Capital Partners to provide weight-inclusive primary care and metabolic health care. They discuss the future of obesity care, where we are with GLP-1s, the need to expand coverage, and more. [0:00] Intro[1:06] Current State of Obesity Medicine[2:47] The knownwell Approach[6:06] Challenges in Obesity Treatment[7:23] The Future of Obesity Medication[12:40] Insurance and Access Issues[32:19] Supply Chain and Distribution[35:38] Final Thoughts and Resources Out-Of-Pocket: https://www.outofpocket.health/
Embed this episode
What this episode covers
Jacob sits down with Dr. Angela Fitch, the Founder and CMO of knownwell. knownwell has raised $25 million from investors like a16z and Flare Capital Partners to provide weight-inclusive primary care and metabolic health care. They discuss the future of obesity care, where we are with GLP-1s, the need to expand coverage, and more.
Ready to play
Ep 52: knownwell CMO Dr. Angela Fitch on The Future of GLP-1s and New Approaches to Obesity Medicine
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.